CID 16131454

[3-[[5-(2-amino-6-oxo-1h-purin-9-yl)-3-[[5-(2-amino-6-oxo-1h-purin-9-yl)-3-[[5-(2-amino-6-oxo-1h-purin-9-yl)-3-[[3-[[5-(2-amino-6-oxo-1h-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl (2-phenylphenyl) hydrogen phosphate

Structural Information

Molecular Formula
C72H83N27O37P6
SMILES
CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=O)(O)OC3=CC=CC=C3C4=CC=CC=C4)OP(=O)(O)OCC5C(CC(O5)N6C=NC7=C6N=C(NC7=O)N)OP(=O)(O)OCC8C(CC(O8)N9C=NC1=C9N=C(NC1=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)O
InChI
InChI=1S/C72H83N27O37P6/c1-30-17-94(72(106)93-63(30)101)47-12-35(41(126-47)19-120-137(107,108)131-34-10-6-5-9-32(34)31-7-3-2-4-8-31)132-139(111,112)122-21-43-37(14-49(128-43)97-27-82-54-60(97)86-69(75)90-65(54)103)135-141(115,116)124-23-45-39(16-51(130-45)99-29-84-56-62(99)88-71(77)92-67(56)105)136-142(117,118)123-22-44-38(15-50(129-44)98-28-83-55-61(98)87-70(76)91-66(55)104)134-140(113,114)121-20-42-36(13-48(127-42)95-25-80-52-57(73)78-24-79-58(52)95)133-138(109,110)119-18-40-33(100)11-46(125-40)96-26-81-53-59(96)85-68(74)89-64(53)102/h2-10,17,24-29,33,35-51,100H,11-16,18-23H2,1H3,(H,107,108)(H,109,110)(H,111,112)(H,113,114)(H,115,116)(H,117,118)(H2,73,78,79)(H,93,101,106)(H3,74,85,89,102)(H3,75,86,90,103)(H3,76,87,91,104)(H3,77,88,92,105)
InChIKey
HUJUKMCISNZPGY-UHFFFAOYSA-N
Compound name
[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl (2-phenylphenyl) hydrogen phosphate
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

2103.387 Da
Monoisotopic Mass

-9.8
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 2104.3943 235.5
[M+Na]+ 2126.3762 246.1
[M-H]- 2102.3797 235.0
[M+NH4]+ 2121.4208 239.0
[M+K]+ 2142.3502 243.0
[M+H-H2O]+ 2086.3843 234.1
[M+HCOO]- 2148.3852 240.0
[M+CH3COO]- 2162.4009 241.8
[M+Na-2H]- 2124.3617 242.7
[M]+ 2103.3865 243.7
[M]- 2103.3875 243.7
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.